Sharekhan

Sai Life Science Ltd

Fri 11/07/2025,15:56:34 | NSE : SAILIFE

₹ 782.15-0.90 (-0.11%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 786.85

Previous Close

₹ 783.05

Volume

929144

Mkt Cap ( Rs. Cr)

₹16311.38

High

₹ 792.85

Low

₹ 776.25

52 Week High

₹ 838.50

52 Week Low

₹ 636.10

Book Value Per Share

₹ 46.38

Dividend Yield

0.00

Face Value

₹ 1.00

What’s Your Call?

Collective community sentiment on Sai Life Science Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

782.15

665

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

665

Option Chain

Analyzes market sentiment, predicts Sai Life Science Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Sai Life Science - Spurt in Volume

    3 Jul 2025, 1:46PM Significant increase in volume has been observed in Sai Life Sciences Limited. The Exchange, in order to ensure that investors have latest relevant in
  • Sai Life Science - General Updates

    3 Jul 2025, 12:33PM Clarification on Increase in Volume
  • Sai Life Science - Updates

    3 Jul 2025, 12:12PM Sai Life Sciences Limited has informed the Exchange regarding 'Clarification on Increase in Volume'.
  • Sai Life Science - Clarification On Increase In Volume

    3 Jul 2025, 12:39PM As per the letter attached
  • Sai Life Science - Clarification sought from Sai Life Sciences Ltd

    3 Jul 2025, 12:32PM The Exchange has sought clarification from Sai Life Sciences Ltd on July 3, 2025, with reference to Movement in Volume.<BR><BR>The reply is awaited.
  • Sai Life Science - Spurt in Volume

    2 Jul 2025, 6:05PM Significant increase in volume has been observed in Sai Life Sciences Limited. The Exchange, in order to ensure that investors have latest relevant in
  • Sai Life Science - Disclosure under SEBI Takeover Regulations

    29 Jun 2025, 9:34PM Sai Life Sciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Sub
  • Sai Life Science - ESOP/ESOS/ESPS

    27 Jun 2025, 11:09AM Sai Life Sciences Limited has informed the Exchange regarding Allotment of 40403 Shares.
  • Sai Life Science - ESOP/ESOS/ESPS

    27 Jun 2025, 11:07AM Revision in intimation under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 ( LODR ) dated 09th June 202
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    27 Jun 2025, 10:54AM Allotment of equity shares under Management ESOP Plan 2018 (\MESOP 2018\).
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    27 Jun 2025, 10:48AM Revision in intimation under regulation 30 of LODR dated 23rd May 2025 and 09 June 2025 with respect to the allotment of equity shares under on exerci
  • Sai Life Science - General Updates

    27 Jun 2025, 10:43AM Allotment of equity shares under Management ESOP Plan 2018 ( MESOP 2018 ).
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    27 Jun 2025, 10:37AM Revision in intimation under Regulation 30 of LODR dated 23rd May 2025 and 09th June 2025 with respect to the allotment of Equity Shares on exercise o
  • Sai Life Science - General Updates

    27 Jun 2025, 10:36AM Revision in Intimation under Regulation 30 of LODR dated 23rd May 2025 and 09th June 2025 with respect to allotment of Equity Shares on exercise of Em
  • Sai Life Science - Trading Window-XBRL

    25 Jun 2025, 4:03PM Sai Life Sciences Limited has informed the Exchange about Closure of Trading Window
  • Sai Life Science - Trading Window

    25 Jun 2025, 4:00PM Sai Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations
  • Sai Life Science - Analysts/Institutional Investor Meet/Con. Call Updates

    20 Jun 2025, 12:46PM Intimation of Investor Meet to be held on 24th and 25th June 2025 at London.
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    20 Jun 2025, 12:43PM Intimation of Investor Meet to be held on 24th and 25th June 2025 at London.
  • Sai Life Science - Intimation For Commencement Of Commercial Operation Of The Second Phase Of The Production - (Unit IV Bidar

    20 Jun 2025, 12:20PM Please refer enclosed intimation.
  • Sai Life Science - General Updates

    20 Jun 2025, 12:13PM Intimation for Commencement of commercial operation of the second phase of the production - ( Unit IV Bidar Facility )
  • Sai Life Science - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    18 Jun 2025, 11:57AM SAI LIFE SCIENCES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer A
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Change in Directorate

    17 Jun 2025, 7:21PM The members have approved Appointment of Dr Dinesh V Patel as Independent Director and Mr. Sivaramakrishnan Chittor as Whole-time Director of the Comp
  • Sai Life Science - Ratification Of ESOP Scheme And Extension Of Benefits To The Employees Of Its Subsidiaries.

    17 Jun 2025, 7:15PM As per the attached
  • Sai Life Science - Updates

    17 Jun 2025, 6:34PM Sai Life Sciences Limited has informed the Exchange regarding 'Ratification of ESOP Schemes and extension of its benefits to the employees of subsidi
  • Sai Life Science - Appointment

    17 Jun 2025, 6:34PM Sai Life Sciences Limited has informed the Exchange regarding Appointment of Mr Sivaramakrishnan Chittor as Executive Director of the company w.e.f. J
  • Sai Life Science - Shareholders meeting

    17 Jun 2025, 11:10AM Sai Life Sciences Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regar
  • Sai Life Science - Shareholders meeting

    17 Jun 2025, 10:53AM Sai Life Sciences Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot
  • Sai Life Science - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    17 Jun 2025, 10:41AM As per the attached
  • Sai Life Science - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    17 Jun 2025, 10:32AM Outcome of Postal Ballot
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    13 Jun 2025, 10:32PM Intimation of Investor Meet to be held on 19th June, 2025 at Hyderabad
  • Sai Life Science - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Jun 2025, 10:29PM Sai Life Sciences Limited has informed the Exchange about Schedule of meet
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    13 Jun 2025, 9:55PM Investor Meet is scheduled to be held on 17th June, 2025 at Hyderabad.
  • Sai Life Science - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Jun 2025, 9:49PM Sai Life Sciences Limited has informed the Exchange about Schedule of meet
  • Sai Life Science - Updates

    10 Jun 2025, 3:21PM Sai Life Sciences Limited has informed the Exchange regarding 'Reply to InGovern Research Services Pvt Ltd on recommendation of Postal Ballot Notice (
  • Sai Life Science - Reply To Ingovern Research Services Pvt Ltd On Recommendation Of Postal Ballot Notice (Under Of SEBI (Issu

    10 Jun 2025, 3:23PM As per the Attached Letter
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Allotment

    9 Jun 2025, 7:23PM Allotment of Equity Shares on conversion of ESOPs.
  • Sai Life Science - Allotment of Securities

    9 Jun 2025, 7:21PM Sai Life Sciences Limited has informed the Exchange regarding allotment of 19000 securities pursuant to ESOP/ESPS at its meeting held on Jun 09, 2025
  • Sai Life Science - Updates

    9 Jun 2025, 5:10PM Sai Life Sciences Limited has informed the Exchange regarding ""Reply to SES on recommendation of Postal Ballot Notice (under of SEBI (Issue of Capita
  • Sai Life Science - Reply To SES On Recommendation Of Postal Ballot Notice (Under Of SEBI (Issue Of Capital And Disclosure Req

    9 Jun 2025, 5:08PM As per the Attached Letter
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    3 Jun 2025, 5:58PM Investor Meet with C-Worldwide Asset Management is scheduled to be held on 11th June, 2025 at Hyderabad.
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    3 Jun 2025, 5:55PM Investor meet with Emkay Global Financial Services is scheduled to be held on 04th June, 2025 at Mumbai.
  • Sai Life Science - Analysts/Institutional Investor Meet/Con. Call Updates

    3 Jun 2025, 5:51PM Sai Life Sciences Limited has informed the Exchange about Schedule of meet
  • Sai Life Science - Analysts/Institutional Investor Meet/Con. Call Updates

    26 May 2025, 11:00AM Sai Life Sciences Limited has informed the Exchange about Schedule of meet
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    26 May 2025, 11:09AM Intimation of meeting with Investor scheduled to be held on 30th May, 2025 with Columbia Threadneedle.
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Allotment

    23 May 2025, 5:51PM Allotment of Equity Shares on Conversion of ESOP.
  • Sai Life Science - Allotment of Securities

    23 May 2025, 5:49PM Sai Life Sciences Limited has informed the Exchange regarding allotment of 174 securities pursuant to ESOP/ESPS at its meeting held on May 22, 2025
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    23 May 2025, 4:02PM Intimation of Investors meeting to be held on Wednesday, June 04, 2025 at Mumbai.
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    23 May 2025, 4:00PM Intimation of Investor meeting to be held on Wednesday, June 04, 2025 at Mumbai.
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    23 May 2025, 3:58PM Intimation of Investors meeting to be held on Wednesday, June 04, 2025 at Mumbai.
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    23 May 2025, 3:54PM Intimation of Investors meeting to be held on Wednesday, June 04, 2025 at Mumbai.
  • Sai Life Science - Analysts/Institutional Investor Meet/Con. Call Updates

    23 May 2025, 3:45PM Sai Life Sciences Limited has informed the Exchange about Schedule of meet
  • Sai Life Science - Analysts/Institutional Investor Meet/Con. Call Updates

    21 May 2025, 3:12PM Sai Life Sciences Limited has informed the Exchange about Transcript
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    21 May 2025, 3:19PM Earnings Call Transcript for Financial Results for the Quarter and Year ended 31st March, 2025.
  • Sai Life Science - Copy of Newspaper Publication

    16 May 2025, 11:29AM Sai Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication
  • Sai Life Science - Copy of Newspaper Publication

    15 May 2025, 6:49PM Sai Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication
  • Sai Life Science - Notice Of Shareholders Meetings-XBRL

    15 May 2025, 4:16PM SAI LIFE SCIENCES LIMITED has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot
  • Sai Life Science - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    15 May 2025, 4:10PM Notice of Postal Ballot
  • Sai Life Science - Shareholders meeting

    15 May 2025, 4:04PM Sai Life Sciences Limited has informed the Exchange regarding Notice of Postal Ballot
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    14 May 2025, 6:18PM Recording of Earnings Call for the Audited Financial results of the Company for the Quarter and Financial Year ended 31st March, 2025
  • Sai Life Science - Analysts/Institutional Investor Meet/Con. Call Updates

    14 May 2025, 6:07PM Sai Life Sciences Limited has informed the Exchange about Link of Recording
  • Sai Life Science - Monitoring Agency Report

    14 May 2025, 4:22PM Monitoring Agency Report for the quarter ended 31 March 2025 in relation to the Initial Public Offer (IPO) of the Company
  • Sai Life Science - Notice Of Shareholders Meetings-XBRL

    14 May 2025, 4:09PM SAI LIFE SCIENCES LIMITED has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot
  • Sai Life Science - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    14 May 2025, 4:08PM SAI LIFE SCIENCES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer A
  • Sai Life Science - Investor Presentation

    14 May 2025, 3:58PM Sai Life Sciences Limited has informed the Exchange about Investor Presentation
  • Sai Life Science - Press Release

    14 May 2025, 1:05PM Sai Life Sciences Limited has informed the Exchange regarding a press release dated May 14, 2025, titled ""Press release for the Financial Results for
  • Sai Life Science - Allotment of Securities

    14 May 2025, 1:20AM Sai Life Sciences Limited has informed the Exchange regarding allotment of 25000 securities pursuant to ESOP/ESPS at its meeting held on May 13, 2025
  • Sai Life Science - Updates

    14 May 2025, 1:15AM Sai Life Sciences Limited has informed the Exchange regarding 'Approval of Postal Ballot Notice'.
  • Sai Life Science - Appointment

    14 May 2025, 1:12AM Sai Life Sciences Limited has informed the Exchange regarding Appointment of Ms P S Rao and Associates as Secretarial Auditors of the company w.e.f. M
  • Sai Life Science - Outcome of Board Meeting

    14 May 2025, 12:36AM Sai Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on May 13, 2025.
  • Sai Life Science - Outcome of Board Meeting

    14 May 2025, 12:10AM Sai Life Sciences Limited has informed the Exchange regarding Board meeting held on May 13, 2025.
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    14 May 2025, 4:26PM Monitoring Agency Report for the Quarter ended 31st March, 2025 in relation to the IPO.
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Investor Presentation

    14 May 2025, 4:02PM Investor Presentation for the year ended 31st March, 2025
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    14 May 2025, 1:12PM Press release for the Financial Results for the quarter and year ended 31st March, 2025.
  • Sai Life Science Q4 net profit jumps 46.24% at Rs 89.94 cr

    14 May 2025, 10:00AM The company reported standalone net profit of Rs 89.94 crore for the quarter ended March 31, 2025 as compared to Rs 61.50 crore in the same period las
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Allotment

    14 May 2025, 1:26AM Allotment of securities as per attachment
  • Sai Life Science - Approved Notice Of Postal Ballot

    14 May 2025, 12:58AM As per the letter attached
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Change in Management

    14 May 2025, 12:52AM As per the attached
  • Sai Life Science - Results- Financial Results For The Period Ending 31St March, 2025

    14 May 2025, 12:12AM Financial results for the Year ending 31st March, 2025
  • Sai Life Science - Analysts/Institutional Investor Meet/Con. Call Updates

    6 May 2025, 6:31PM Sai Life Sciences Limited has informed the Exchange about Schedule of meet
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    6 May 2025, 6:29PM Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Sai Life Science - Board Meeting Intimation

    6 May 2025, 4:30PM SAI LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 13-May-2025 to consider and approve the Yearly Audited Financial
  • Sai Life Science - Board Meeting Intimation for Notice Of Board Meeting

    6 May 2025, 4:24PM Sai Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2025 ,inter alia, to consider an
  • Sai Life Science - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    29 Apr 2025, 1:32PM SAI LIFE SCIENCES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer A
  • Sai Life Science - Appointment

    28 Apr 2025, 5:20PM Sai Life Sciences Limited has informed the Exchange regarding Appointment of Mr Sivaramakrishnan Chittor as Additional Director of the company w.e.f.
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Change in Directorate

    28 Apr 2025, 5:16PM Appointment of Mr. Sivaramakrishnan Chittor (DIN: 01092158) as Additional Director of the Company.
  • Sai Life Science - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    24 Apr 2025, 5:35PM SAI LIFE SCIENCES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer A
  • Sai Life Science - Change in Management

    23 Apr 2025, 5:01PM Sai Life Sciences Limited has informed the Exchange about change in Management
  • Sai Life Science - Allotment of Securities

    23 Apr 2025, 4:40PM Sai Life Sciences Limited has informed the Exchange regarding allotment of 46510 securities pursuant to ESOP/ESPS at its meeting held on April 23, 202
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Change in Management

    23 Apr 2025, 4:50PM As pe the attached document.
  • Sai Life Science - Announcement under Regulation 30 (LODR)-Allotment

    23 Apr 2025, 4:37PM Allotment of Equity Shares on exercise of options under ESOP.
  • Sai Life Science has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    17 Apr 2025, 11:50AM As of March 2025, 35.17% is owned by Promoters and 64.83% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 33.47% and Fore
  • Sai Life Science - Clarification sought from Sai Life Sciences Ltd

    16 Apr 2025, 11:54AM The Exchange has sought clarification from Sai Life Sciences Ltd on April 16, 2025, with reference to Movement in Volume. <BR><BR>The reply is awaited

Key fundamentals

Evaluate the intrinsic value of Sai Life Science Ltd stock 

Name March-25 March-24 March-23 March-22
Assets 2296.1 1721.361 1611.961 1642.3565
Liabilities 2296.1 1721.361 1611.961 1642.3565
Equity 20.841 17.663 17.623 17.5563
Gross Profit 390.446 286.61 163.141 121.3909
Net Profit 173.462 95.231 24.237 15.6826
Cash From Operating Activities 330.351 250.642 221.474 88.3798
NPM(%) 10.56 6.71 2.09 1.86
Revenue 1642.048 1418.682 1157.403 841.0228
Expenses 1251.602 1132.072 994.262 719.6319
ROE(%) 17.93 9.84 2.5 1.62

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Sai Life Science Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 905.60 0.25 30.05 446.93 301.39 0.55
Lotus Eye Hospital and Institute Ltd 73.05 -1.14 208.71 1628.56 3.55 0.00
Vaishali Pharma Ltd 12.76 -0.23 212.67 839.42 3.13 0.00
Astec Lifesciences Ltd 893.55 -0.53 0.00 1535.77 -601.21 0.00

Company Info

Our Company was originally incorporated as `Sai Dru Syn Laboratories Limited' at Hyderabad, Telangana (erstwhile Andhra Pradesh) as a public limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. Our Company received the certificate of commencement of business from Registrar of Companies, Andhra Pradesh at Hyderabad on February 17, 1999. Subsequently, the name of our Company was changed from `Sai Dru Syn Laboratories Limited' to `Sai Life Sciences Limited' pursuant to a Shareholders' resolution in an extraordinary general meeting held on December 11, 2003 and a fresh certificate of incorporation dated December 16, 2003 consequent to change of name was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. Thereafter, the name of the Company was changed from `Sai Life Sciences Limited' to `Sai Advantium Pharma Limited' pursuant to a Shareholders' resolution in an extraordinary general meeting held on August 16, 2006 and a fresh certificate of incorporation dated August 30, 2006 consequent to change of name was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. Subsequently, the name of our Company was changed from `Sai Advantium Pharma Limited' to its present name, `Sai Life Sciences Limited' pursuant to a Shareholders' resolution in an extraordinary general meeting held on April 20, 2012 and a fresh certificate of incorporation dated May 28, 2012 consequent to change of name was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.Major Events and Milestones:1999- Incorporation of our Company2002- Inauguration of our R&D labs in ICICI Knowledge Park, Hyderabad.2004- Strategic acquisitions of Prasad Drugs Limited, the current Unit III Bolarum Facility2006- Investment by Advantium LLC in our Company to set-up discovery services to expand our Company's business.- Acquired Merrifield Pharma Private Limited2007- Acquisition of shares of our Company held by Advantium LLC by Sequoia Capital India Investments III2008- Investment by MPM Investment Mauritius in our Company2014- Acquisition of shares of our Company held by MPM Investment Mauritius and Sequoia Capital India Investment III by Tata Capital Healthcare Fund 12016- Acquisition of shares of our Company held by MPM Investment Mauritius by HBM Private Equity India and subscription to shares of our Company2019- Opened biology facility in Watertown (Greater Boston, MA) U.S.A2020- Launched Sai Nxt, an initiative aiming to transform the organization into a new generation CDMO- Addition of cellular analysis platforms at our discovery biology facility in Cambridge, Massachusetts, USA2021- Opened new 75,000 sq. ft. discovery biology facility at our integrated R&D campus at Unit II Hyderabad Facility2022- Inauguration of the first set of new discovery chemistry labs as part of the new integrated discovery block at Unit II Hyderabad Facility- Announced the launch of BIOVIA Electronic Lab Notebook application. 2022 -Sai Life Sciences inks strategic agreement to set up Schr”dinger's first dedicated offshore Research Laboratories in India. -Sai Life Sciences wins National Award for Excellence in Energy Management for the third consecutive year. 2023 - Inauguration of high potency API manufacturing block at Unit IV Bidar Facility. -Sai Life Sciences wins Gold in Brandon Hall Group's Excellence in Technology Awards. 2024 - Initiated API developability & formulations (D&F) capabilities at Unit II Hyderabad. -Sai Life Sciences completes restoration of historic Manchirevula stepwell.

Our Company was originally incorporated as `Sai Dru Syn Laboratories Limited' at Hyderabad, Telangana (erstwhile Andhra Pradesh) as a public limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. Our Company received the certificate of commencement of business from Registrar of Companies, Andhra Pradesh at Hyderabad on February 17, 1999. Subsequently, the name of our Company was changed from `Sai Dru Syn Laboratories Limited' to `Sai Life Sciences Limited' pursuant to a Shareholders' resolution in an extraordinary general meeting held on December 11, 2003 and a fresh certificate of incorporation dated December 16, 2003 consequent to change of name was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. Thereafter, the name of the Company was changed from `Sai Life Sciences Limited' to `Sai Advantium Pharma Limited' pursuant to a Shareholders' resolution in an extraordinary general meeting held on August 16, 2006 and a fresh certificate of incorporation dated August 30, 2006 consequent to change of name was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. Subsequently, the name of our Company was changed from `Sai Advantium Pharma Limited' to its present name, `Sai Life Sciences Limited' pursuant to a Shareholders' resolution in an extraordinary general meeting held on April 20, 2012 and a fresh certificate of incorporation dated May 28, 2012 consequent to change of name was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.Major Events and Milestones:1999- Incorporation of our Company2002- Inauguration of our R&D labs in ICICI Knowledge Park, Hyderabad.2004- Strategic acquisitions of Prasad Drugs Limited, the current Unit III Bolarum Facility2006- Investment by Advantium LLC in our Company to set-up discovery services to expand our Company's business.- Acquired Merrifield Pharma Private Limited2007- Acquisition of shares of our Company held by Advantium LLC by Sequoia Capital India Investments III2008- Investment by MPM Investment Mauritius in our Company2014- Acquisition of shares of our Company held by MPM Investment Mauritius and Sequoia Capital India Investment III by Tata Capital Healthcare Fund 12016- Acquisition of shares of our Company held by MPM Investment Mauritius by HBM Private Equity India and subscription to shares of our Company2019- Opened biology facility in Watertown (Greater Boston, MA) U.S.A2020- Launched Sai Nxt, an initiative aiming to transform the organization into a new generation CDMO- Addition of cellular analysis platforms at our discovery biology facility in Cambridge, Massachusetts, USA2021- Opened new 75,000 sq. ft. discovery biology facility at our integrated R&D campus at Unit II Hyderabad Facility2022- Inauguration of the first set of new discovery chemistry labs as part of the new integrated discovery block at Unit II Hyderabad Facility- Announced the launch of BIOVIA Electronic Lab Notebook application. 2022 -Sai Life Sciences inks strategic agreement to set up Schr”dinger's first dedicated offshore Research Laboratories in India. -Sai Life Sciences wins National Award for Excellence in Energy Management for the third consecutive year. 2023 - Inauguration of high potency API manufacturing block at Unit IV Bidar Facility. -Sai Life Sciences wins Gold in Brandon Hall Group's Excellence in Technology Awards. 2024 - Initiated API developability & formulations (D&F) capabilities at Unit II Hyderabad. -Sai Life Sciences completes restoration of historic Manchirevula stepwell.

Read More

Parent Organisation

Sai Life Science Ltd.

Founded

25/01/1999

Managing Director

Mr.Krishnam Raju Kanumuri

NSE Symbol

SAILIFEEQ

FAQ

The current price of Sai Life Science Ltd is ₹ 782.15.

The 52-week high for Sai Life Science Ltd is ₹ 792.85 and the 52-week low is ₹ 776.25.

The market capitalization of Sai Life Science Ltd is currently ₹ 16311.38. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Sai Life Science Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Sai Life Science Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Sai Life Science Ltd shares.

The CEO of Sai Life Science Ltd is Mr.Krishnam Raju Kanumuri, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT